Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1001918

	registered interest
	date	05/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Rare Diseases: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether officials in his Department have had discussions with the Scottish Government on the (a) Patient and Clinician Engagement system, (b) its effect on approval rates for new rare disease medicines in Scotland and (c) potential lessons from that system for NHS England.
	tabling member constituency	Bury North
	tabling member printed	James Frith
	uin	188233
	answer	answer is ministerial correction date of answer 14/11/2018 answer text <p>Officials have had no such discussions. Health is a devolved matter and the availability of medicines for the treatment of rare diseases in Scotland is an issue for the Scottish Government.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/11/2018 11:21:33 answering member 4067 label Biography information for Steve Brine
	tabling member	4637 label Biography information for James Frith

1001919

	registered interest
	date	05/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Rare Diseases: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to paragraph 4.12 the UK Rare Diseases Strategy, what assessment his Department has made of whether the National Institute for Health and Care Excellence’s Single Technology Appraisal Programme meets the ambition of suitability for assessing rare disease treatments.
	tabling member constituency	Bury North
	tabling member printed	James Frith
	uin	188234
	answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>Where a company is willing to set a fair price for a drug, the National Institute for Health and Care Excellence (NICE) technology appraisal process has been proven to be suitable for the assessment of drugs for rare diseases. NICE has been able to recommend a number of drugs for patients with rare diseases through its technology appraisal programme; recent examples include dinutuximab beta for neuroblastoma and daratumumab for relapsed and refractory multiple myeloma.</p><p> </p><p>With the aim of improving the lives of all those affected by a rare disease, the United Kingdom Government published the UK Strategy for Rare Diseases in 2013, a high-level framework containing 51 commitments which sets out a seven-year strategic vision (2013-2020). The Government is committed to implementing the Strategy’s commitments and has, in January 2018, published Implementation Plans setting out its actions for England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/11/2018 17:23:30 answering member 4067 label Biography information for Steve Brine
	tabling member	4637 label Biography information for James Frith

1020384

	registered interest
	date	05/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when NHS England plans to publish the commercial framework referred to in the policy paper of 5 December 2018 entitled Voluntary scheme for branded medicines pricing and access.
	tabling member constituency	Bury North
	tabling member printed	James Frith
	uin	199471
	answer	answer is ministerial correction date of answer 12/12/2018 answer text <p>NHS England, with input from the National Institute for Health and Care Excellence, will develop a ’commercial framework’ setting out the parameters for the commercial approach for medicines in the health service in England. This framework will be tested with and informed through consultation with stakeholders once the voluntary scheme is operational. The intention is to publish the framework early in 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/12/2018 15:03:23 answering member 4067 label Biography information for Steve Brine
	tabling member	4637 label Biography information for James Frith

825489

	registered interest
	date	18/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many Units of Dental Activity were delivered in (a) Bury North constituency, (b) Greater Manchester and (c) England in each of the last five years.
	tabling member constituency	Bury North
	tabling member printed	James Frith
	uin	123628
	answer	answer is ministerial correction date of answer 25/01/2018 answer text <p>The following table shows the information available on number of units of dental activity delivered for Bury Local Authority, Greater Manchester and England. Data is available for Bury Local Authority, Greater Manchester for 2013/14 to 2016/17 and England for 2012/13 to 2016/17. Data is not available broken down by constituency.</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Bury Local Authority</p></td><td><p>Greater Manchester<sup>1</sup></p></td><td><p>England</p></td></tr><tr><td><p>2016-17</p></td><td><p>320,578</p></td><td><p>4,952,821</p></td><td><p>85,731,304</p></td></tr><tr><td><p>2015-16</p></td><td><p>337,942</p></td><td><p>4,985,119</p></td><td><p>86,350,897</p></td></tr><tr><td><p>2014-15</p></td><td><p>336,160</p></td><td><p>4,978,641</p></td><td><p>87,220,891</p></td></tr><tr><td><p>2013-14</p></td><td><p>334,639</p></td><td><p>4,985,364</p></td><td><p>88,691,434</p></td></tr><tr><td><p>2012-13</p></td><td><p>-</p></td><td><p>-</p></td><td><p>88,097,804</p></td></tr></tbody></table><p>Source: NHS Digital</p><p> </p><p>Note:</p><p> </p><p><sup>1</sup>Greater Manchester is defined as the following local authorities: Bolton, Bury, Manchester, Oldham, Rochdale, Salford, Stockport, Tameside, Trafford and Wigan.</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 25/01/2018 15:56:01 answering member 4067 label Biography information for Steve Brine
	tabling member	4637 label Biography information for James Frith

825491

	registered interest
	date	18/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dentistry: Migrant Workers
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many overseas qualified dentists are waiting for a Performer Number by country of origin; and what the the average waiting time has been to receive such a number in each of the last three years.
	tabling member constituency	Bury North
	tabling member printed	James Frith
	uin	123630
	answer	answer is ministerial correction date of answer 25/01/2018 answer text <p>Information is not held centrally on the number of dentists who qualified overseas who are waiting for a Performer Number or on the average turnaround time for applications to join the National Dental Performers List.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 25/01/2018 13:47:20 answering member 4067 label Biography information for Steve Brine
	tabling member	4637 label Biography information for James Frith

827972

	registered interest
	date	22/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many NHS dental contracts were not completed in each of the last five years; and how many units of dental activity were undelivered in each case.
	tabling member constituency	Bury North
	tabling member printed	James Frith
	uin	123932
	answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>This information is not held centrally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/01/2018 14:20:04 answering member 4067 label Biography information for Steve Brine
	tabling member	4637 label Biography information for James Frith

861034

	registered interest
	date	13/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Rare Diseases: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of NICE's consideration of drugs for rare diseases.
	tabling member constituency	Bury North
	tabling member printed	James Frith
	uin	132183
	answer	answer is ministerial correction date of answer 21/03/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent an effective use of NHS resources.</p><p> </p><p>NICE assesses most significant new drugs through its technology appraisal programme and has been able to recommend a number of drugs licenced for the treatment of rare diseases for routine use on the NHS. NICE also operates a separate highly specialised technology evaluation programme for the assessment of very high cost drugs for the treatment of very small numbers of patients.</p><p> </p><p>NICE’s methods and processes for the assessment of drugs have been carefully developed over time and are internationally respected. NICE continues to keep its procedures under periodic review to ensure that they remain effective.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/03/2018 13:47:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4637 label Biography information for James Frith

864329

	registered interest
	date	15/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescriptions: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he plans to amend the list of long-term and orphan diseases which qualify for free prescriptions; and when he last consulted (a) patients, (b) doctors and (c) those in the (i) pharmaceutical and (ii) health industries on that subject.
	tabling member constituency	Bury North
	tabling member printed	James Frith
	uin	132813
	answer	answer is ministerial correction date of answer 23/03/2018 answer text <p>We have no current plans to amend the list of long-term and orphan diseases which qualify for free prescriptions. The last consultation on this issue was as part of Professor Sir Ian Gilmore’s review in 2008, which included consultation with patients, the public and general practitioners.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/03/2018 14:18:42 answering member 4067 label Biography information for Steve Brine
	tabling member	4637 label Biography information for James Frith

864331

	registered interest
	date	15/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Primary Care Support England
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, which Key Performance Indicators (KPI) apply to the patients registration area of work carried out by Primary Care Support England (PCSE); how often PCSE reported against those KPIs; which targets were reached and how many complaints were received on those targets in each of the last three years.
	tabling member constituency	Bury North
	tabling member printed	James Frith
	uin	132815
	answer	answer is ministerial correction date of answer 23/03/2018 answer text <p>Primary Care Support England services are provided by Capita Business Services Ltd under contract with NHS England. The contract contains service standards, including Key Performance Indicators (KPIs) that specify the agreed measurement and evaluation of performance delivery. The KPIs relating to patient registration, medical records, local performers list, local medical committee, pensions and general practitioner payments are attached.</p><p> </p><p>NHS England closely monitors delivery of the services against these performance standards, which are reported by Capita on a monthly basis. However, information relating to targets and complaints is commercially sensitive and therefore we are unable to provide this information.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 132816 132817 132818 132819 132820 question first answered 23/03/2018 14:40:55 answering member 4067 label Biography information for Steve Brine attachment 1 file name PCSE KPI List.docx title PQ132815 attached document
	tabling member	4637 label Biography information for James Frith

864332

	registered interest
	date	15/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Primary Care Support England
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, which Key Performance Indicators (KPI) apply to the medical records area of work carried out by Primary Care Support England (PCSE); how often PCSE reported against those KPIs; which targets were reached and how many complaints were received on those targets in each of the last three years.
	tabling member constituency	Bury North
	tabling member printed	James Frith
	uin	132816
	answer	answer is ministerial correction date of answer 23/03/2018 answer text <p>Primary Care Support England services are provided by Capita Business Services Ltd under contract with NHS England. The contract contains service standards, including Key Performance Indicators (KPIs) that specify the agreed measurement and evaluation of performance delivery. The KPIs relating to patient registration, medical records, local performers list, local medical committee, pensions and general practitioner payments are attached.</p><p> </p><p>NHS England closely monitors delivery of the services against these performance standards, which are reported by Capita on a monthly basis. However, information relating to targets and complaints is commercially sensitive and therefore we are unable to provide this information.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 132815 132817 132818 132819 132820 question first answered 23/03/2018 14:40:55 answering member 4067 label Biography information for Steve Brine attachment 1 file name PCSE KPI List.docx title PQ132815 attached document
	tabling member	4637 label Biography information for James Frith